SEC Form D private-offering filing

Crossject SA

Name: Crossject SA - new SEC Form D private-offering filing, Dijon
Published: 2026-06-05

A new SEC Form D private-offering notice from Dijon, a $10,259,936 filer-stated offering target in Biotech. The source filing is one click away.

Crossject SA site↗ Verified via SEC Form D

French specialty pharmaceutical company developing ZENEO, a needle free auto injector for rapid delivery of emergency medications such as epinephrine and anti epileptic rescue therapy.

Filed 2026-06-05Filed to raise $10,259,936First money in 2026-05-27HQ (as filed) DijonSector Biotech ✓Stage (inferred) EarlyCall status Needs classification

Source linked the Form D on EDGAR↗Website verified crossject.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.